Abstract:O-linked N-acetylglucosamine (O-GlcNAc) is an emerging post-translation modification that couples metabolism with cellular signal transduction by crosstalking with phosphorylation and ubiquitination to orchestrate various biological processes. Herein we show that it modifies the N6-methyladenosine (m6A)-mRNA reader YTHDF1 and fine-tunes its nuclear translocation by the exportin protein Crm1. First we present evidence that YTHDF1 interacts with the sole O-GlcNAc transferase (OGT). Second, we verified the YTHDF1 O-GlcNAcylation sites to be Ser196/Ser197/Ser198, as described in previous numerous chemoproteomic studies. Then we constructed the O-GlcNAc-deficient YTHDF1-S196AS197FS198A (AFA) mutants, which significantly attentuated O-GlcNAc signals. Moreover, we revealed that YTHDF1 is a nucleocytoplasmic protein, whose nuclear export is mediated by Crm1. Furthermore, O-GlcNAcylation increases the cytosolic portion of YTHDF1 by enhancing binding with Crm1, thus upregulating the downstream target (e.g. c-Myc) expression. Molecular dynamics simulations suggest that O-GlcNAcylation at S197 might promote the binding between the nuclear export signal motif and Crm1 through increasing hydrogen bonding. Mouse xenograft assays further demonstrate that YTHDF1-AFA mutants decreased the colon cancer mass and size via decreasing c-Myc expression. In sum, we found that YTHDF1 is a nucleocytoplasmic protein, whose cytosolic localization is dependent on O-GlcNAc modification. We propose that the OGT-YTHDF1-c-Myc axis might underlie colorectal cancer tumorigenesis.### Competing Interest StatementThe authors have declared no competing interest.* (TMG) : Thiamet-G (MS) : Mass spectrometry (IP) : Immunoprecipitation (IB) : Immunoblotting (5S-G) : Acetyl-5S-GlcNAc (O-GlcNAc) : O-linked β-N-acetylglucosamine (OGT) : O-GlcNAc transferase (m6A) : mRNA N6-methyladenosine (ETD) : electron transfer dissociation

O-GlcNAc transferase promotes the nuclear localization of the focal adhesion–associated protein Zyxin to regulate UV-induced cell death

O-GlcNAcylation regulates epidermal growth factor receptor intracellular trafficking and signaling

One-Step Enzymatic Labeling Reveals a Critical Role of O-GlcNAcylation in Cell-Cycle Progression and DNA Damage Response

O-GlcNAcylation regulates phagocytosis by promoting Ezrin localization at the cell cortex

O-GlcNAcylation stimulates the deubiquitination activity of USP16 and regulates cell cycle progression

O-GlcNAcylation promotes the cytosolic localization of the m6A reader YTHDF1 and colorectal cancer tumorigenesis

O-GlcNAcylation of YY1 Stimulates Tumorigenesis in Colorectal Cancer Cells by Targeting SLC22A15 and AANAT

O-GlcNAcylation Promotes YTHDF1 Cytosolic Localization and Colorectal Cancer Tumorigenesis

UV Irradiation Triggers Cylindromatosis Translocation, Modification, and Degradation in a Proteasome-Independent Manner.

Lysine Acetylation and Succinylation in HeLa Cells and Their Essential Roles in Response to UV-induced Stress

O-GlcNAcylation Promotes Pancreatic Tumor Growth by Regulating Malate Dehydrogenase 1

O-GlcNAc Has Crosstalk with ADP-ribosylation Via PARG.

O-GlcNAcylation Promotes Colorectal Cancer Progression by Regulating Protein Stability and Potential Catcinogenic Function of DDX5

O-GlcNAcylation of YTHDF2 antagonizes ERK-dependent phosphorylation and inhibits lung carcinoma

O-GlcNAcylation mediates H 2 O 2 -induced apoptosis through regulation of STAT3 and FOXO1

A Pathway from JNK Through Decreased ERK and Akt Activities for FOXO3a Nuclear Translocation in Response to UV Irradiation.

DNA damage-induced YTHDC1 O-GlcNAcylation promotes homologous recombination by enhancing m6A binding

GSK-3β phosphorylation of DHX33 leads to its ubiquitination mediated protein degradation

O-GlcNAcylation of Focal Adhesion Kinase Regulates Cell Adhesion, Migration, and Proliferation via the FAK/AKT Pathway

Zyxin As a Potential Cancer Prognostic Marker Promotes the Proliferation and Metastasis of Colorectal Cancer Cells.

O-GlcNAcylation in tumorigenesis and its implications for cancer therapy